Browsing: Longevity

As resolutions drive demand, regulators warn against fake, illegal weight-loss medicines circulating online and on social media. For many, the…

Global longevity therapeutics market projected to hit US$43.72b by 2033, as supplements and antiaging solutions move from niche to mainstream.…

Hopeful mouse data suggest restoring the brain’s energy balance could do what decades of research have not: push Alzheimer’s into…

GLP-1 drugs help with weight and heart health, but a review finds they may not meaningfully lower the risk of…

China’s speed, scale and infrastructure are central to Insilico’s ambition to build a ‘digital Einstein’ for faster, cheaper drug discovery.…

Nephrodite’s device designed to ‘free patients from the cycle of center-based dialysis’ becomes the first to receive the designation.  …

Innovation meets economic caution as life sciences leaders prepare for 2026, balancing investment and regulation in a shifting global market.…

Data-rich heart scans are fused with AI to spot drug opportunities faster, offering clearer path for future of cardiovascular innovation.…

Autophagy-enhancing drug candidate enters Phase 1 trial as longevity focused biotech eyes Alzheimer’s as a potential first indication. Longevity biotech…

Insilico Medicine IPO signals that AI‑native drug discovery is moving from promise to public markets with a central longevity narrative.…